All News

2019

July

Media Release / Jul 02, 2019

Novartis highlights cognition data in secondary progressive multiple sclerosis (SPMS)

Read More
Media Release / Jul 01, 2019

Novartis successfully completes acquisition of Xiidra®, bolstering ophthalmic portfolio

Read More
Media Release / Jul 01, 2019

Novartis data show Aimovig® cuts acute migraine medication days by half in patients who failed prior preventive therapies

Read More
Media Release / Jul 01, 2019

Novartis data underpin long-term efficacy of Aimovig® where other treatments have failed

Read More

June

Media Release / Jun 26, 2019

Novartis highlights new publication showing IL-17A antibody Cosentyx® improves inflammation and rapidly suppresses IL-23 in plaque psoriasis

Read More
Story / Jun 25, 2019

Flexibility at Novartis: Christine Sturchler and Aileen Wrynn

Sturchler and Wrynn explain why their job-sharing experience was one of the most successful and energizing periods of their careers.

Read More
Media Release / Jun 24, 2019

Novartis provides update on phase 2b ENCORE-LF trial in NASH cirrhosis

Read More
Sickle cell disease patient, Nana, poses in Ghana to share her story
Featured News / Jun 19, 2019

World Sickle Cell Day 2019

For over 40 years Novartis has been committed to understanding sickle cell disease and working towards treatment.

Read More
Media Release / Jun 17, 2019

New analysis of Novartis data confirms that Cosentyx® demonstrates durable comprehensive treatment across psoriatic disease

Read More
Media Release / Jun 14, 2019

New Sandoz biosimilar adalimumab data confirms switching from reference biologic has no impact on safety or efficacy

Read More

Related Links

Novartis Annual Reporting Suite

Read and download the Annual Review, the Annual Report and Form 20-F, and the Novartis in Society report.

Learn More